Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar 29;378(13):1169-1171.
doi: 10.1056/NEJMp1716871.

Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic

T Jake Liang  1 , John W Ward  1
Affiliations

Hepatitis C in Injection-Drug Users - A Hidden Danger of the Opioid Epidemic

T Jake Liang et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Estimated Number of New Hepatitis B and Hepatitis C Infections in the United States, by Year
Data are from the Centers for Disease Control and Prevention and are adjusted for the expected number of people with acute hepatitis B virus and HCV infections who become symptomatic, seek medical care, and are reported to state or local public health surveillance.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Zibbell JE, Asher AK, Patel RC, et al. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108:175–81. - PMC - PubMed
    1. Patrick SW, Bauer AM, Warren MD, Jones TF, Wester C. Hepatitis C virus infection among women giving birth — Tennessee and United States, 2009–2014. MMWR Morb Mortal Wkly Rep. 2017;66:470–3. - PMC - PubMed
    1. Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39–49. - PubMed
    1. Grebely J, Dalgard O, Conway B, et al. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. Lancet Gastroenterol Hepatol. 2018 Jan 5; (Epub ahead of print) - PubMed
    1. Günthard HF, Saag MS, Benson CA, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2016 recommendations of the International Antiviral Society-USA Panel. JAMA. 2016;316:191–210. - PMC - PubMed

Substances